shutterstock_1407371705_dcstockphotography

DCStockPhotography / Shutterstock.com

15 September 2022BiotechnologyStaff Writer

US company secures genetically modified rice ban against Chinese rival

Kansas-based company wins block on infringing plant-based albumins | Genetically programmed rice expresses human proteins used in immunotherapy drugs, gene therapies and vaccines.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

USITC to probe alleged engineered-rice theft by Chinese company

19 January 2021 The US International Trade Commission is to investigate allegations that a Chinese company infringed patents held by Ventria Bioscience by importing genetically-engineered rice seeds for medical purposes.

UPDATED: ITC blocks Chinese imports of rice-derived rHSA products after ALJ review

20 October 2022 Commission overturns one ALJ finding but affirms all others, agreeing that Wuhan Healthgen infringed Ventria's rice seed patent | Dispute concerns recombinant human proteins derived from genetically engineered rice.

More on this story

USITC to probe alleged engineered-rice theft by Chinese company

19 January 2021 The US International Trade Commission is to investigate allegations that a Chinese company infringed patents held by Ventria Bioscience by importing genetically-engineered rice seeds for medical purposes.

UPDATED: ITC blocks Chinese imports of rice-derived rHSA products after ALJ review

20 October 2022 Commission overturns one ALJ finding but affirms all others, agreeing that Wuhan Healthgen infringed Ventria's rice seed patent | Dispute concerns recombinant human proteins derived from genetically engineered rice.

More on this story

USITC to probe alleged engineered-rice theft by Chinese company

19 January 2021 The US International Trade Commission is to investigate allegations that a Chinese company infringed patents held by Ventria Bioscience by importing genetically-engineered rice seeds for medical purposes.

UPDATED: ITC blocks Chinese imports of rice-derived rHSA products after ALJ review

20 October 2022 Commission overturns one ALJ finding but affirms all others, agreeing that Wuhan Healthgen infringed Ventria's rice seed patent | Dispute concerns recombinant human proteins derived from genetically engineered rice.

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts

WBD to merge with firm to create ‘powerhouse’ practice

‘Be prepared, and don’t assume at the UPC’: Christopher Stothers